Why would Walmart launch an insurance education service for the 140 million Americans who shop its stores each week? For one thing, because more than 60% of Americans have a tough time understanding their health insurance plan options, according to research from the Kaiser Family Foundation, and nearly 40% feel that they picked the wrong plan after enrolling.
Mergers and acquisitions among pharmaceutical companies has kicked into high gear this year, mirroring the larger trend sweeping across the entire spectrum of the health care industry since the implementation of the Affordable Care Act two years ago.
What is the CVS Health competitive edge? To answer that question, CVS Health president and CEO Larry Merlo took the stage Wednesday during the UBS Global Healthcare Conference, a three-day conference in New York City that brings together investors and more than 200 companies across a variety of healthcare sectors.
The National Association of Chain Drug Stores chairman’s gavel officially traded hands last month, here, at NACDS Annual Meeting, as Rite Aid chairman and CEO John Standley wrapped up his one-year term, and incoming chairman Randy Edeker, chairman, CEO and president of Hy-Vee embarked on his.
As the country’s healthcare system continues to move away from a fee-for-service structure, retail-based clinics are taking on added significance for the operators of these facilities and their patients.
A new and radically different concept for frontline health care emerged last year when Walmart unveiled its first Walmart Care Clinics in Texas, Georgia and South Carolina. If things go according to plan, patients and health plan payers across the United States can look forward to a cheaper and more affordable alternative to the family doctor for nearly all their primary care needs.
The retail behemoth that is Wal-Mart Stores Inc. is fixing its sights on a new target: the nation’s overstretched and overly costly primary healthcare system. The result could be a major disruption of that system and the acceleration of health reform in America.
In lead-up to Thursday’s Senate Finance Committee hearing, “A Pathway to Improving Care for Medicare Patients with Chronic Conditions,” the National Association of Chain Drug Stores submitted comments highlighting pharmacy’s role in helping patients manage their chronic conditions.
Drug Store News on Sunday caught up with Brian McNamara, region head of Europe and the Americas of the recently christened GSK Consumer Healthcare, representing the joint venture between GlaxoSmithKline and Novartis to talk about what a consolidating OTC market means for the industry, and how GSK will be coming to market.